Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
R
Remedium Lifecare Ltd
Score 48/100• Risky
Remedium Lifecare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health35/100
Valuation 80/100 · PB 1.8086
Technical Avoid
1M -39.597% 6M -21.053% 1Y -76%
Confidence100%
No promoter pledgeReasonable PB valuation
High debt/equityThin margins
#166
View details ➜
M
Medistep Healthcare Ltd
Score 48/100• Risky
Medistep Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health100/100
Valuation 60/100 · PB 2.2276
Technical Avoid
1M 4.554% 6M -47.567% 1Y -47.567%
Confidence100%
Low leverage (D/E)No promoter pledge
#167
View details ➜
Z
Zenotech Laboratories Ltd
Score 48/100• Decent
Zenotech Laboratories Ltd shows potential but faces significant challenges in profitability and market sentiment.
Company’s Health79/100
Valuation 60/100 · PB 2.9287
Technical Avoid
1M -9.65% 6M -26.279% 1Y -37.65%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#168
View details ➜
Z
Zenlabs Ethica Ltd
Score 48/100• Risky
Zenlabs Ethica Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment.
Company’s Health41/100
Valuation 80/100 · PB 1.4243
Technical Avoid
1M -30.622% 6M -29.546% 1Y -45.315%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#169
View details ➜
V
Vista Pharmaceuticals Ltd
Score 48/100• Risky
Vista Pharmaceuticals Ltd shows potential but faces significant risks and challenges in growth and profitability.
Company’s Health38/100
Valuation 80/100 · PB 1.1424
Technical Avoid
1M -1.455% 6M -26.933% 1Y -27.577%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#170
View details ➜
V
Vineet Laboratories Ltd
Score 48/100• Risky
Vineet Laboratories Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment.
Company’s Health29/100
Valuation 60/100 · PB 2.7021
Technical Avoid
1M -5.114% 6M 40.327% 1Y -18.21%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#171
View details ➜
V
Venus Remedies Ltd
Score 48/100• Risky
Venus Remedies Ltd presents a mixed outlook with significant risks overshadowing its potential growth. Investors should exercise caution.
Company’s Health72/100
Valuation 80/100 · PB 1.9669
Technical Momentum
1M 60.655% 6M 85.192% 1Y 142.444%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#172
View details ➜
T
Transgene Biotek Ltd
Score 48/100• Risky
Transgene Biotek Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health58/100
Valuation 100/100 · PB -2.8803
Technical Avoid
1M -26.685% 6M -29.481% 1Y -58.182%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#173
View details ➜
S
Supriya Lifescience Ltd
Score 48/100• Decent
Supriya Lifescience Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised for new investors.
Company’s Health100/100
Valuation 20/100 · PB 6.011
Technical Avoid
1M 0.168% 6M 6.38% 1Y -1.547%
Confidence100%
Low leverage (D/E)No promoter pledge
#174
View details ➜
P
Prism Medico and Pharmacy Ltd
Score 48/100• Risky
Prism Medico and Pharmacy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 100/100 · PB 0.7293
Technical Avoid
1M -9.476% 6M 20.358% 1Y -27.429%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#175
View details ➜
J
JFL Life Sciences Ltd
Score 48/100• Decent
JFL Life Sciences Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health82/100
Valuation 100/100 · PB 0.9574
Technical Avoid
1M -15.185% 6M -32.448% 1Y -64.606%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#176
View details ➜
J
Jeena Sikho Lifecare Ltd
Score 48/100• Risky
Jeena Sikho Lifecare Ltd presents several risks with inconsistent growth and weak profitability metrics, making it a risky investment at this time.
Company’s Health98/100
Valuation 20/100 · PB 32.2885
Technical Avoid
1M -5.747% 6M 64.969% 1Y 50.865%
Confidence100%
Low leverage (D/E)No promoter pledge
#177
View details ➜
S
Syncom Formulations (India) Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health88/100
Valuation 40/100 · PB 4.0989
Technical Avoid
1M -7.716% 6M -31.716% 1Y -31.371%
Confidence100%
Low leverage (D/E)No promoter pledge
#178
View details ➜
S
Sunrest Lifescience Ltd
Score 48/100• Risky
Sunrest Lifescience Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health78/100
Valuation 80/100 · PB 1.1404
Technical Avoid
1M -8.898% 6M -14% 1Y -21.818%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#179
View details ➜
S
Solara Active Pharma Sciences Ltd Partly Paidup
Score 48/100• Decent
The stock shows potential but carries risks that warrant caution. Investors should monitor performance closely.
Company’s Health0/100
Valuation 0/100 · PB —
Technical Avoid
1M 8.924% 6M 68.459% 1Y -3.082%
Confidence80%
#180
View details ➜
Showing 166 to 180 of 260 (18 Pages)